BMO Capital Markets highlighted the potential risks faced by Real Estate Investment Trusts (REITs) specializing in Skilled Nursing Facilities (SNFs) due to possible changes in Federal Medical ...
BMO Capital Markets reaffirmed their Outperform rating on Beam Therapeutics Inc (NASDAQ:BEAM), with a steady price target of $57.00. Currently trading at $26.57, the stock appears undervalued ...
BMO Capital downgraded Q32 Bio (QTTB) to Market Perform from Outperform with a price target of $3, down from $22. The company announced an ...
Evolve’s announcement comes after Canada-listed crypto ETFs reported net redemptions in 2024. Investment fund analysts have chalked this up to investors switching to U.S.-listed crypto ETFs, which ...
BMO Capital raised the firm’s price target on IGM Financial (IGIFF) to C$48 from C$47 and keeps a Market Perform rating on the shares.Maximize ...
The "Strategic Intelligence: Wealth Management Sector Scorecard 2025" report has been added to ResearchAndMarkets.com's offering. Digital investment platforms have been a hot topic in the wealth ...
Each week, we summarize notable moves across the financial industry. Duane Green has been appointed as CEO, Canada and head of Americas distribution with Aviva In ...
BILL Holdings, Inc., a cloud-based payment and spend management solution provider for small businesses, has seen its stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results